Illumina (NASDAQ:ILMN)

biotech

Illumina Gets a Reset

Illumina Inc. (NASDAQ: ILMN) reported its second-quarter financial results on Wednesday before the markets opened. The company had $0.80 in earnings per share (EPS) on $539 million in revenue, compared ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Apple, Exxon, LifeLock, Microsoft, PayPal, Chipotle and More

Stocks were lower on Wednesday morning as investors are selling more earnings reports. Still, the one trend that has held up for almost four years now is that investors have ...
Read Full Story »
biotech

Top Health Care Earnings for the Week Ahead

Earnings season is hitting its stride next week, and we have taken a look at companies in a variety of sectors that will be posting results next week. The health ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: BofA, Google, Intel, Fairchild, Mobileye, NOV and More

Stocks were mixed on Friday, looking for direction. One issue is that stocks have rallied handily and the Greek deal looks closer but is still in the air. Shanghai was ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Atmel, BlackBerry, Cisco, Ctrip.com, CarMax, AOL and More

Stocks were in rally mode on Thursday morning, with DJIA futures up 100 and S&P futures up 12. Are the markets going to challenge new highs again? Investors just keep ...
Read Full Story »
buy sell

5 Big Stocks That Are Expected to Outperform Apple

It seems as though every single investor is still in love with Apple Inc. (NASDAQ: AAPL). The earnings report was solid, and the company's dividend and buyback plan will end ...
Read Full Story »
Rite Aid

3 Top Stocks to Buy That Delivered Great Earnings

While often the top firms on Wall Street take a shot and advise clients to buy stocks in front of earnings, that only works when they actually beat earnings and ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: AcelRx, AECOM, EA, HP, Myriad, Urban Outfitters and More

Stocks were getting pounded on Tuesday after weak overseas data. Still, the main theme that has remained for well over two years now is that investors have become trained to ...
Read Full Story »
145922793

5 Top Credit Suisse Health Care Stock Picks to Buy for 2015

As one of the top sectors in the S&P 500 in 2014, health care has one factor that almost always makes it a reasonably safe place to invest in. The ...
Read Full Story »
Pills

Analyst’s 8 Top Health Care Stocks for 2015

Health care had an outstanding year in 2014. In fact the sector through last Friday was up 23.30%, which placed it third in the S&P 500 sector race, just behind ...
Read Full Story »
buy sell

11 Very Popular Stocks Now Valued Over 50 Times Earnings

2014 has been another great year for stocks, with gains of more than 10% in the Dow Jones Industrial Average and in the S&P 500 Index. That being said, some ...
Read Full Story »
DNA

New Cancer Detection Technique Has Enormous Potential for Life Science Stocks

One of the medical scourges of our era is the increase in cancer cases, not only in the United States, but around the world. One of the most important keys ...
Read Full Story »
biotech

Why Everyone Likes Illumina Again

Illumina Inc. (NASDAQ: ILMN) reported its earnings before the market opened Monday as $0.77 in earnings per share and $481 in revenue which beat out consensus estimates. On the heels ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: AmEx, Baidu, BofA, Citi, Lululemon, Netflix, Tiffany and More

Stocks were getting smacked lower again on Thursday morning. While that elusive 10% market correction is closer and closer to fruition, investors still are willing to keep buying value and ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: AECOM, Intercept, Kinder Morgan, Rackspace, SunEdison, Disney and More

Stocks were holding on to small gains on Tuesday even after weaker sentiment was reported out of Europe. It looks as though investors have decided they can now shop around ...
Read Full Story »